The management of hypertension involves the reduction of hypertension stages but may be Increased by examining and prognosticating stop-organ damage. Present-day assessment of endorgan damage, however, relies on biochemical parameters or ultrasound / magnetic resonance / computed tomography imaging.Simultaneously, a managed injection of sclerosant